Advarra Achieves 1,000+ Site Milestone for its Gene Therapy Ready Network
Research involving gene therapy-based treatments can start more quickly with Advarra’s growing network of registered research sites.
FDA Guidance on Shedding and Environmental Impact in Clinical Trials Involving Gene Therapy Products
Our IBC experts authored “FDA Guidance on Shedding and Environmental Impact in Clinical Trials Involving Gene Therapy Products” in Applied Biosafety.
A Guide for Successful Cell and Gene Therapy Research
Understand the unique regulatory, clinical, and manufacturing requirements for cell and gene therapy research.
Safe Sharps Handling When Dispensing Investigational Products
Care must be taken to avoid sharps-related injuries and exposures when preparing investigational products for clinic transportation.
Clean Bench vs Biosafety Cabinet: What’s the Difference?
Using hoods with biological materials depends on directional airflow, and specialized airflow is necessary when handling hazardous materials.
Four Questions to Ask When Establishing a Pharmacovigilance Organization
Four common but critical questions for emerging biotech organizations establishing a pharmacovigilance (PV) organization.
Clinical Trial Superheroes
Download this eBook to learn about the individuals who dedicate their talents to give patients an opportunity for healthier and longer lives.
mRNA Clinical Trials: Key Regulatory Considerations
Responses to the most frequently asked questions regarding mRNA technology and clinical trial regulatory requirements.
Gene Therapy Ready Site Network
This info sheet describes Advarra’s Gene Therapy Ready site network and the benefits of joining the network
Advarra’s Support for Institutions
Find out how we keep site centricity at the forefront through our technology, services, and extraordinary team members.
ABSA International Appoints Advarra Executive Daniel Eisenman as Scientific Program Committee Co-Chair
The American Biological Safety Association International appointed Advarra's Daniel Eisenman as co-chair of its Scientific Program Committee.
The Advantages of Outsourcing IRB and IBC Reviews to One Partner
By utilizing a vendor that offers both IRB and IBC services in-house, sponsors can streamline reviews and enhance study startup timelines.